QIAGEN Backs UK Initiative to Sequence 100,000 Newborn Genomes QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a strategic partnership with Genomics England to support the ambitious Generation Study,…
Wearable Data Integrated into EHR for Personalized Care by Validic At CES, Validic, a leader in digital health and personalized care technology, unveiled a new integration of physical activity data…
Collaboration Between Team Gleason and Synchron Expands BCI Efforts Synchron, a leading brain-computer interface (BCI) company, and Team Gleason, a foundation focused on enhancing the lives of individuals living with…
Conference Preview: Avenacy Updates 2025 Strategy Ahead of J.P. Morgan Healthcare Event Avenacy, a specialty pharmaceutical company focused on providing critical injectable medications, has shared updates regarding its recent business…
Foot & Ankle: Fusion Orthopedics Strategically Expands Reach Fusion Orthopedics USA, LLC (“Fusion”) has announced the successful expansion of its product portfolio with the acquisition of Metalogix External Fixation Systems.…
Certification Achieved by ModMed for AI-Powered Scribe by ASTP/ONC ModMed®, a leading innovator in healthcare technology, announced that its electronic health records (EHR) platform, EMA®, has successfully achieved certification from…
Merz Group Unveils New OTC Business Player for the New Year At the turn of the year, Merz Lifecare and WindStar Medical completed their merger, resulting in the formation of…
Invests $150M in Patho Care via PathoCare Holdings, Hamershlag Private Capital Hamershlag Private Capital Management Limited (HPCM), a prominent health technology investment firm, invests in Patho Care, LLC, a leading…
Analgesic from Xgene Pharmaceutical Reduces Pain and Opioid Use in Post-Surgical Trial Xgene Pharmaceutical has revealed further findings from a positive, multi-center, placebo-controlled, dose-ranging Phase 2b study (registration number: NCT06017999)…
Series E and E1 Warrant Exercises Secure $16.3 Million for Delcath Systems Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company dedicated to treating primary and metastatic liver cancers, announced…
CEL-SCI Prices $5 Million Public Offering CEL-SCI Corporation (NYSE American: CVM), a clinical-stage immunotherapy company focused on cancer treatments, today announced the pricing of a public offering of 16,130,000 shares…
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, has announced the appointment of Wendy Warren…